Resuscitative TEE Collaborative Registry
Launched by UNIVERSITY OF PENNSYLVANIA · Jul 19, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Resuscitative TEE Collaborative Registry is a clinical trial aimed at understanding how a specific heart imaging test called transesophageal echocardiography (TEE) can help critically-ill patients, particularly those experiencing cardiac arrest or shock. This study is focused on patients over the age of 18 who are in emergency or intensive care settings and receive this heart imaging as part of their regular medical care. The researchers want to find out how safe this procedure is and how it affects patient care and outcomes.
If you or a loved one is a critically-ill adult and might receive focused TEE during treatment, you may be eligible to participate in this study. Participants can expect to have their heart images taken while they are receiving care, and the researchers will track various details like how often the test is used, the reasons for its use, and any complications that may arise. It's important to note that children and certain vulnerable populations are not included in this trial, as the focus is solely on adult patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult critically-ill patients who as part of their routine clinical care receive focused TEE in the emergency department of intensive care setting.
- Exclusion Criteria:
- • Children (age under 18 years)
- • Vulnerable populations
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Felipe Teran, MD, MSCE
Study Chair
Weill Medical College of Cornell University
Benjamin Abella, MD, MPhil
Study Director
University of Pennsylvania
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials